Influence of polymeric precipitation inhibitors on dissolution behaviour of Meloxicam

  • Karnati V Chandana Department of Pharmaceutics, JSS College of Pharmacy, Sri Shivarathreeshwara Nagara, Mysuru, JSS Academy of Higher Education and Research, JSS Medical Institutions Campus, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India
  • Gowda DV Department of Pharmaceutics, JSS College of Pharmacy, Sri Shivarathreeshwara Nagara, Mysuru, JSS Academy of Higher Education and Research, JSS Medical Institutions Campus, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India
  • Vishal Gupta N Department of Pharmaceutics, JSS College of Pharmacy, Sri Shivarathreeshwara Nagara, Mysuru, JSS Academy of Higher Education and Research, JSS Medical Institutions Campus, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India
  • Praveen Sivadasu Department of Pharmaceutics, JSS College of Pharmacy, Sri Shivarathreeshwara Nagara, Mysuru, JSS Academy of Higher Education and Research, JSS Medical Institutions Campus, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India
  • Manjunath M Department of Pharmaceutics, Farooqia College of Pharmacy, Mysuru– 570015, Karnataka, India

Abstract

The scope of this study was to analyse the effect of polymeric precipitation inhibitor on in-vitro dissolution of Meloxicam which is a weak acid, water-insoluble and a crystalline compound. Meloxicam is used to treat pain or inflammation caused by rheumatoid arthritis. HPMC was used as polymeric precipitation inhibitor. Solvent evaporation method was employed to formulate solid dispersions with and without polymeric precipitation inhibitor.IR spectra suggested that there were no interactions between drug and polymers used in the study. DSC thermograms indicated that the drug was completely miscible with the molten carrier. Amorphization of the drug in the solid dispersion was established by a reduction in the enthalpy of drug melting in solid dispersion versus pure drug. The drug crystallinity in the solid dispersion was found to be reduced from X-ray Diffraction analysis. SEM analysis showed that Meloxicam exhibited irregular crystals, but the surface morphology of solid dispersions was smooth. Formulated solid dispersions showed increased solubility than the pure drug. Meloxicam solid dispersions with HPMC exhibited less precipitation rate compared to the Meloxicam solid dispersions without HPMC. Increase in the dissolution was attributed to the decrease in crystallinity of the drug and inhibition of drug precipitation. Thus, dissolution of Meloxicam can be enhanced by formulating solid dispersion using polymeric precipitation inhibitors.

Article Level Metrics

Download data is not yet available.
Published
2018-10-31
How to Cite
V CHANDANA, Karnati et al. Influence of polymeric precipitation inhibitors on dissolution behaviour of Meloxicam. International Journal of Research in Pharmaceutical Sciences, [S.l.], v. 9, n. 4, p. 1299-1305, oct. 2018. ISSN 0975-7538. Available at: <https://pharmascope.org/index.php/ijrps/article/view/1677>. Date accessed: 12 dec. 2018. doi: https://doi.org/10.26452/ijrps.v9i4.1677.
Section
Original Articles
Bookmark and Share